Skip to main content

OP/Bone

    RT @VeenaRheumMD: Dr. Lane on Ca/Vitamin D in Osteoporosis
    ⭐️🎯serum vitamin D 25OH ~38
    ⭐️Studies since 2008
    2 years 5 months ago
    Dr. Lane on Ca/Vitamin D in Osteoporosis ⭐️🎯serum vitamin D 25OH ~38 ⭐️Studies since 2008 Auckland Calcium trial DO NOT support incr CV risk with Ca supplementation ⭐️Ca calculator: https://t.co/PLPMfZdIwb ⭐️No sig change in fracture risk with supp #ACR21 #ACRAmbassador https://t.co/KUa52vf4gT
    RT @RichardPAConway: Dr Adachi presents ⬆️BMD gain with denosumab than risedronate in RA. Non-significant reduction
    2 years 5 months ago
    Dr Adachi presents ⬆️BMD gain with denosumab than risedronate in RA. Non-significant reduction in fractures (very small numbers) Interesting, but need to see fracture benefit in larger study to justify dmab as first line Abstr#0445 #ACR21 @RheumNow https://t.co/GgaS9JZGzb
    RT @synovialjoints: A meta-analysis of 5 cohort studies showed that PsA is significantly associated with vertebral fract
    2 years 5 months ago
    A meta-analysis of 5 cohort studies showed that PsA is significantly associated with vertebral fractures pooled OR 2.09 (95% CI, 1.11 – 3.96; I2 70%). The review was not suggestive of publication bias @RheumNow #ACR21 Abst#1304 https://t.co/rjC776FXUA https://t.co/QvMWxN6ZZ7
    RT @RichardPAConway: Meta-analysis shows increased risk of vertebral fracture in PsA, OR 2.09. Abstr#1304 #ACR21 @RheumN
    2 years 5 months ago
    Meta-analysis shows increased risk of vertebral fracture in PsA, OR 2.09. Abstr#1304 #ACR21 @RheumNow https://t.co/kTrR7I3HA0
    RT @ericdeinmd: #ACR21 A#0563 - Is FRAX score applicable for RA? 10 yr Olmsted County epi study: Yes
    ▶️ 76 osteoporo
    2 years 5 months ago
    #ACR21 A#0563 - Is FRAX score applicable for RA? 10 yr Olmsted County epi study: Yes ▶️ 76 osteoporotic fxs in RA pts, FRAX predicted 67 fx (SIR 1.13, not signif) ▶️ 21 observed hip fx, FRAX predicted 23.3 (SIR 0.9) ⭐️ No differences by ages/sex https://t.co/vWy7EmseZp @Rheumnow https://t.co/8BlzgQYqaV
    RT @ericdeinmd: @jhrheumatology Dr. Petri at #ACR21 Great Debate.
    Safety issues with Voclosporin:
    1) Nephrotoxicity
    2) I
    2 years 5 months ago
    @jhrheumatology Dr. Petri at #ACR21 Great Debate. Safety issues with Voclosporin: 1) Nephrotoxicity 2) Infection 3) CV Risk Factors 4) Malignancy 5) Neurologic toxicity 6) Osteoporosis 7) Drug interactions 8) Deaths 9) Pregnancy contraindication @RheumNow https://t.co/wjluivmKNt